Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Rudolf

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Trends in Pharmacological Sciences|October 30, 2007
CGRP antagonists: unravelling the role of CGRP in migraineHenri Doods, Kirsten Arndt, Klaus Rudolf, et al.
Optics Express|August 6, 2008
Microspectrometer based on holographically recorded diffractive elements using supplementary hologramsRobert Brunner, Matthias Burkhardt, Klaus Rudolf, et al.
Archives of Dermatological Research|January 25, 2012
Studies of cell signaling in a reconstructed human epidermis exposed to sensitizers: IL-8 synthesis and release depend on EGFR activationAurélie Frankart, Alain Coquette, Klaus-Rudolf Schroeder, et al.
Bioorganic & Medicinal Chemistry Letters|August 1, 2009
Studies towards topical selective beta2-adrenoceptor agonists with a long duration of actionThierry Bouyssou, Klaus Rudolf, Christoph Hoenke, et al.
Artificial Intelligence in Medicine|June 1, 2026
A critical perspective on finite sample conformal prediction theory in medical applicationsKlaus-Rudolf Kladny, Bernhard Schölkopf, Lisa Koch, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 31, 2013
Acetaminophen changes intestinal epithelial cell membrane properties, subsequently affecting absorption processesChristine Schäfer, Klaus Rudolf Schröder, Otmar Höglinger, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2009
Use of 5-hydroxy-4H-benzo[1,4]oxazin-3-ones as beta2-adrenoceptor agonistsChristoph Hoenke, Thierry Bouyssou, Christofer S Tautermann, et al.
Journal of Medicinal Chemistry|September 16, 2005
Development of human calcitonin gene-related peptide (CGRP) receptor antagonists. 1. Potent and selective small molecule CGRP antagonists. 1-[N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-l-lysyl]-4-(4-pyridinyl)piperazine: the first CGRP antagonist for clinical trials in acute migraineKlaus Rudolf, Wolfgang Eberlein, Wolfhard Engel, et al.
Bioorganic & Medicinal Chemistry Letters|January 26, 2010
Discovery of olodaterol, a novel inhaled beta2-adrenoceptor agonist with a 24 h bronchodilatory efficacyThierry Bouyssou, Christoph Hoenke, Klaus Rudolf, et al.
Bioorganic & Medicinal Chemistry Letters|June 17, 2015
Design, synthesis and evaluation of MCH receptor 1 antagonists--Part II: Optimization of pyridazines toward reduced phospholipidosis and hERG inhibitionGerald J Roth, Armin Heckel, Jörg T Kley, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Trends in Pharmacological Sciences|October 30, 2007
CGRP antagonists: unravelling the role of CGRP in migraineHenri Doods, Kirsten Arndt, Klaus Rudolf, et al.
Optics Express|August 6, 2008
Microspectrometer based on holographically recorded diffractive elements using supplementary hologramsRobert Brunner, Matthias Burkhardt, Klaus Rudolf, et al.
Archives of Dermatological Research|January 25, 2012
Studies of cell signaling in a reconstructed human epidermis exposed to sensitizers: IL-8 synthesis and release depend on EGFR activationAurélie Frankart, Alain Coquette, Klaus-Rudolf Schroeder, et al.
Bioorganic & Medicinal Chemistry Letters|August 1, 2009
Studies towards topical selective beta2-adrenoceptor agonists with a long duration of actionThierry Bouyssou, Klaus Rudolf, Christoph Hoenke, et al.
Artificial Intelligence in Medicine|June 1, 2026
A critical perspective on finite sample conformal prediction theory in medical applicationsKlaus-Rudolf Kladny, Bernhard Schölkopf, Lisa Koch, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 31, 2013
Acetaminophen changes intestinal epithelial cell membrane properties, subsequently affecting absorption processesChristine Schäfer, Klaus Rudolf Schröder, Otmar Höglinger, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2009
Use of 5-hydroxy-4H-benzo[1,4]oxazin-3-ones as beta2-adrenoceptor agonistsChristoph Hoenke, Thierry Bouyssou, Christofer S Tautermann, et al.
Journal of Medicinal Chemistry|September 16, 2005
Development of human calcitonin gene-related peptide (CGRP) receptor antagonists. 1. Potent and selective small molecule CGRP antagonists. 1-[N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-l-lysyl]-4-(4-pyridinyl)piperazine: the first CGRP antagonist for clinical trials in acute migraineKlaus Rudolf, Wolfgang Eberlein, Wolfhard Engel, et al.
Bioorganic & Medicinal Chemistry Letters|January 26, 2010
Discovery of olodaterol, a novel inhaled beta2-adrenoceptor agonist with a 24 h bronchodilatory efficacyThierry Bouyssou, Christoph Hoenke, Klaus Rudolf, et al.
Bioorganic & Medicinal Chemistry Letters|June 17, 2015
Design, synthesis and evaluation of MCH receptor 1 antagonists--Part II: Optimization of pyridazines toward reduced phospholipidosis and hERG inhibitionGerald J Roth, Armin Heckel, Jörg T Kley, et al.
Pageof 2